MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dopamine agonists"

  • 2019 International Congress

    Prospective study on impulsive-compulsive behaviours in early Parkinson’s disease

    V. Markovic, I. Stankovic, I. Petrovic, T. Stojkovic, V. Kostic (Belgrade, Serbia)

    Objective: To assess longitudinally impulsive-compulsive behaviours (ICBs) in a cohort of Parkinson's disease (PD) patients at the initial stage of the disease during 5 years…
  • 2019 International Congress

    Shedding light on the relationship between dyskinesia assessed by a wearable device and impulsive compulsive behaviour in Parkinson’s disease

    F. Morgante, A. de Angelis, C. Siri, M. Horne, A. Leake, D. Paviour, M. Edwards, L. Ricciardi (London, United Kingdom)

    Objective: To evaluate the relationship between the presence of dyskinesia objectively detected using a wearable device and the presence of active and past impulsive compulsive…
  • 2019 International Congress

    Abnormal posture during treatment of restless legs syndrome in an old woman: A case report

    K. Hirata, K. Suzuki, M. Saito, T. Shiina, H. Sakuramoto, M. Hamaguchi, T. Kadowaki (Mibu, Japan)

    Objective: To report a patient with restless legs syndrome (RLS) in whom abnormal posture appeared during treatment of that. Background: Abnormal posture such as camptocormia…
  • 2019 International Congress

    Restless Genital Syndrome in a patient with Dementia with Lewy Body

    M. Abu Al-Melh, M. Farghal, B. Al-Failakawii (Kuwait, Kuwait)

    Objective: To report the co-existence of Restless Genital Syndrome (RGS) and Dementia with Lewy Body (DLB), and to highlight the responsiveness to rotigotine (dopamine agonist)…
  • 2019 International Congress

    Trends in first line therapy for PD in Wales: A 16 year observational study

    K. Orayj, A. Lacey, A. Akbari, O. Pickrell, E. Lane (Cardiff, United Kingdom)

    Objective: To examine the changes in first line therapy of newly diagnosed Parkinson’s patients between 2000 and 2016 in Wales. Background: There have been several…
  • 2019 International Congress

    Parkinson’s disease polygenic risk score is not associated with impulse control disorders: a longitudinal study

    J. Ihle, F. Artaud, S. Bekadar, G. Magnone, H. Bertrand, S. Sambin, LL. Mariani, C. Scherzer, A. Elbaz, JC. Cornol (Paris, France)

    Objective: To examine the relationship between a polygenic risk score (GRS) associated with Parkinson’s disease (PD) and impulse control disorders (ICDs) in PD. Background: Genome…
  • 2019 International Congress

    Impulse control disorders and (romantic) jealousy in Parkinson’s disease: a patients’ vs. partners’ perspective

    E. Pipan, S. Delalić, A. Herzog, M. Trošt, Z. Pirtošek, D. Flisar, N. Kovacs, D. Georgiev (Ljubljana, Slovenia)

    Objective: To compare self-reported symptoms of (romantic) jealousy and impulse control disorders (ICD) in Parkinson’s disease (PD) patients to those reported by their partners. Background:…
  • 2019 International Congress

    Longitudinal analysis of the relation between trajectories of dopaminergic agonists use and BMI in Parkinson’s disease

    F. Artaud, PC. Lee, M. Vidailhet, JC. Corvol, A. Elbaz (Saint-Aubin, France)

    Objective: To describe the longitudinal relation between dopaminergic agonists (DA) use and change of BMI in a longitudinal cohort of PD patients followed annually up…
  • 2018 International Congress

    Emulating the natural timing of dopamine receptor activation in Parkinson’s Disease

    J. Reynolds, B. Hyland, J. Wickens, E. Tan (Dunedin, New Zealand)

    Objective: To emulate physiological dopamine receptor activation, in order to restore temporal patterns of dopamine-like signalling and normalise function in the striatum in Parkinson's disease.…
  • 2018 International Congress

    GASTROPARK: Multicenter study on the efficacy of dopamine agonists for gastrointestinal symptoms in Parkinson’s disease

    J. Martinez Castrillo, A. Alonso Canovas, G. Fernandez Pajarin, L. Vela Desojo, J. Garcia Caldentey, P. Sanchez Alonso, M. Fernandez Moreno, M. Mata, J. Herreros Rodriguez, J. Infante, J. Ruiz Martinez, C. Ruiz Huete, S. Fanjul Arbos, P. Garcia Ruiz (Madrid, Spain)

    Objective: Main: To assess the modification of gastrointestinal symptoms in patients with Parkinson's disease before and after the introduction of dopamine agonists. Secondary: (1) To…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 13
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley